CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL)

340 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q2 2017.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45,975,742 shares of 50,495,188 outstanding shares and own 91.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,060,730 shares), BlackRock Inc. (4,022,882 shares), FMR LLC (3,079,179 shares), ARIEL INVESTMENTS, LLC (1,950,367 shares), STATE STREET CORP (1,268,308 shares), MILLENNIUM MANAGEMENT LLC (1,228,039 shares), RENAISSANCE TECHNOLOGIES LLC (1,219,883 shares), AQR CAPITAL MANAGEMENT LLC (1,106,522 shares), MORGAN STANLEY (954,648 shares), and Bank of New York Mellon Corp (840,643 shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.